SC 13D Filing

Company

CytoMed Therapeutics Ltd

Filed

April 21, 2023

Accession Number

0001493152-23-013202

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →